Maven Securities »

Fulcrum Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 100k 11.31

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Adage Capital Partners GP
Point72 Asset Management
First Turn Management
Balyasny Asset Management
D. E. Shaw & Co
Ikarian Capital
ADAR1 Capital Management
Standard Life Aberdeen

View all funds holding Fulcrum Therapeutics